NCT06633562View on ClinicalTrials.gov

A Study to Test the Effects of Nezavist At Different Doses in Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

December 1, 2025

Conditions
HealthySafety Evaluation of Escalating DosesTolerability
Interventions
DRUG

Nezavist SDD

Formulated as a spray dried dispersion (SDD) suspended in a flavored diluent.

DRUG

Placebo

Formulated in a diluent that matches the Nezavist SDD suspension in appearance.

Trial Locations (1)

92037

RECRUITING

The Altman Clinical and Translational Research Institute, La Jolla

Sponsors
All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Lohocla Research Corporation

INDUSTRY

NCT06633562 - A Study to Test the Effects of Nezavist At Different Doses in Healthy Adults | Biotech Hunter | Biotech Hunter